Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Adverse events associated with childhood vaccines [[electronic resource] ] : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
| Adverse events associated with childhood vaccines [[electronic resource] ] : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1994 |
| Descrizione fisica | xvi, 464 p |
| Disciplina | 615/.372/083 |
| Altri autori (Persone) |
StrattonKathleen R
HoweCynthia J JohnstonRichard B. <1935-> |
| Soggetto topico |
Vaccination of children - Complications
Vaccines - Health aspects Vaccines - Toxicology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19665-3
9786610196654 0-309-57632-6 0-585-15869-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910455874003321 |
| Washington, D.C., : National Academy Press, 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse events associated with childhood vaccines : evidence bearing on causality / / editors, Kathleen R. Stratton, Cynthia J. Howe, Richard B. Johnston, Jr
| Adverse events associated with childhood vaccines : evidence bearing on causality / / editors, Kathleen R. Stratton, Cynthia J. Howe, Richard B. Johnston, Jr |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 1994 |
| Descrizione fisica | 1 online resource (480 pages) |
| Disciplina | 615/.372/083 |
| Altri autori (Persone) |
StrattonKathleen R
HoweCynthia J JohnstonRichard B. <1935-> |
| Soggetto topico |
Vaccination of children - Complications
Vaccines - Health aspects Vaccines - Toxicology |
| ISBN |
1-280-19665-3
9786610196654 0-309-57632-6 0-585-15869-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778791603321 |
| Washington, D.C. : , : National Academy Press, , 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse events associated with childhood vaccines : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
| Adverse events associated with childhood vaccines : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1994 |
| Descrizione fisica | 1 online resource (480 pages) |
| Disciplina | 615/.372/083 |
| Altri autori (Persone) |
StrattonKathleen R
HoweCynthia J JohnstonRichard B. <1935-> |
| Soggetto topico |
Vaccination of children - Complications
Vaccines - Health aspects Vaccines - Toxicology |
| ISBN |
1-280-19665-3
9786610196654 0-309-57632-6 0-585-15869-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Adverse Events Associated with CHILDHOOD VACCINES -- Copyright -- Preface -- Acknowledgments -- Contents -- 1 Executive Summary -- BACKGROUND AND HISTORY -- THE CHARGE TO THE COMMITTEE -- THE STUDY PROCESS -- CAUSALITY AND WEIGHT OF EVIDENCE -- NEED FOR RESEARCH AND SURVEILLANCE -- REFERENCES -- 2 Causality and Evidence -- CAUSALITY -- Definitions -- Types of Causal Questions -- Can It? -- Did It? -- Will It? -- SOURCES OF EVIDENCE FOR CAUSALITY -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Combining the Evidence -- SUMMARIZING THE EVIDENCE FOR CAUSALITY -- REFERENCES -- 3 Neurologic Disorders -- DEMYELINATING DISEASE -- Experimental Models -- Acute Disseminated Encephalomyelitis -- Multiple Sclerosis -- Focal Lesions -- Guillain-Barré Syndrome -- Historical Background -- Clinical and Laboratory Features -- Diagnostic Criteria -- Antecedent Events -- Pathology and Pathogenesis -- Descriptive Epidemiology -- Summary of Demyelinating Diseases -- NON-DEMYELINATING DISEASE -- Encephalopathy -- Subacute Sclerosing Panencephalitis -- Clinical and Laboratory Features -- Pathology and Pathogenesis -- Descriptive Epidemiology -- Residual Seizure Disorder -- Sensorineural Deafness -- Neuropathy -- Mononeuropathy -- Brachial Neuritis -- REFERENCES -- 4 Immunologic Reactions -- ANAPHYLAXIS -- INTERACTION OF ANTIBODY WITH NORMAL TISSUE ANTIGENS -- ARTHUS REACTION -- DELAYED-TYPE HYPERSENSITIVITY -- EFFECT OF VACCINES ON THE IMMUNE SYSTEM -- REFERENCES -- 5 Diphtheria and Tetanus Toxoids -- BACKGROUND AND HISTORY -- Tetanus -- Diphtheria -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- Tetanus -- Diphtheria -- ENCEPHALOPATHY -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility.
Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- RESIDUAL SEIZURE DISORDER -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series. and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- NEUROPATHY -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- ARTHRITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ERYTHEMA MULTIFORME -- Clinical Description -- History of Suspected Association. Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ANAPHYLAXIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- DEATH -- Causality Argument -- Conclusion -- REFERENCES -- 6 Measles and Mumps Vaccines -- BACKGROUND AND HISTORY -- Measles -- Mumps -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- Measles -- Mumps -- ENCEPHALOPATHY AND ENCEPHALITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- SUBACUTE SCLEROSING PANENCEPHALITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- RESIDUAL SEIZURE DISORDER -- Clinical Description -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies. Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- SENSORINEURAL DEAFNESS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- OPTIC NEURITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- TRANSVERSE MYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Studies, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- INSULIN-DEPENDENT DIABETES MELLITUS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- STERILITY DUE TO ORCHITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies. Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- ANAPHYLAXIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- DEATH -- Causality Argument -- Conclusion -- REFERENCES -- 7 Polio Vaccines -- BACKGROUND AND HISTORY -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- POLIOMYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- TRANSVERSE MYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors. ANAPHYLAXIS AND THROMBOCYTOPENIA. |
| Record Nr. | UNINA-9910827558403321 |
| Washington, D.C., : National Academy Press, 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Multiple sclerosis [[electronic resource] ] : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine
| Multiple sclerosis [[electronic resource] ] : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2001 |
| Descrizione fisica | 1 online resource (456 p.) |
| Disciplina | 616.8/34 |
| Altri autori (Persone) |
JoyJanet E <1953-> (Janet Elizabeth)
JohnstonRichard B. <1935-> |
| Soggetto topico |
Multiple sclerosis
Neurology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-51175-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""List of Tables and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Clinical and Biological Features""; ""3 Characteristics and Management of Major Symptoms""; ""4 Disease Management and Measurement""; ""5 Strategies for Future Research on Disease Mechanisms""; ""6 Future Strategies for MS Therapies""; ""7 Building and Supporting the Research Enterprise""; ""8 Recommendations""; ""Appendix A Committee and Staff Biographies""; ""Appendix B List of Expert Consultants""; ""Appendix C Workshop Agendas""
""Appendix D Kurtzke�s Expanded Disability Status Scale (EDSS)""""Appendix E Drugs Used in the Treatment of MS""; ""Appendix F U.S. Social Security Administration�s Criteria for Qualifying as Disabled from MS""; ""Appendix G Treatments That Have Been Claimed to Be of Benefit in MS1""; ""Index"" |
| Record Nr. | UNINA-9910456021003321 |
| Washington, D.C., : National Academy Press, c2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Multiple sclerosis [[electronic resource] ] : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine
| Multiple sclerosis [[electronic resource] ] : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2001 |
| Descrizione fisica | 1 online resource (456 p.) |
| Disciplina | 616.8/34 |
| Altri autori (Persone) |
JoyJanet E <1953-> (Janet Elizabeth)
JohnstonRichard B. <1935-> |
| Soggetto topico |
Multiple sclerosis
Neurology |
| ISBN |
0-309-17130-X
0-309-51175-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""List of Tables and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Clinical and Biological Features""; ""3 Characteristics and Management of Major Symptoms""; ""4 Disease Management and Measurement""; ""5 Strategies for Future Research on Disease Mechanisms""; ""6 Future Strategies for MS Therapies""; ""7 Building and Supporting the Research Enterprise""; ""8 Recommendations""; ""Appendix A Committee and Staff Biographies""; ""Appendix B List of Expert Consultants""; ""Appendix C Workshop Agendas""
""Appendix D Kurtzke�s Expanded Disability Status Scale (EDSS)""""Appendix E Drugs Used in the Treatment of MS""; ""Appendix F U.S. Social Security Administration�s Criteria for Qualifying as Disabled from MS""; ""Appendix G Treatments That Have Been Claimed to Be of Benefit in MS1""; ""Index"" |
| Record Nr. | UNINA-9910778610603321 |
| Washington, D.C., : National Academy Press, c2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Multiple sclerosis : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine
| Multiple sclerosis : current status and strategies for the future / / Janet E. Joy and Richard B. Johnston, Jr., editors ; Committee on Multiple Sclerosis: Current Status and Strategies for the Future, Board on Neuroscience and Behavioral Health, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2001 |
| Descrizione fisica | 1 online resource (456 p.) |
| Disciplina | 616.8/34 |
| Altri autori (Persone) |
JoyJanet E <1953-> (Janet Elizabeth)
JohnstonRichard B. <1935-> |
| Soggetto topico |
Multiple sclerosis
Neurology |
| ISBN |
0-309-17130-X
0-309-51175-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""List of Tables and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Clinical and Biological Features""; ""3 Characteristics and Management of Major Symptoms""; ""4 Disease Management and Measurement""; ""5 Strategies for Future Research on Disease Mechanisms""; ""6 Future Strategies for MS Therapies""; ""7 Building and Supporting the Research Enterprise""; ""8 Recommendations""; ""Appendix A Committee and Staff Biographies""; ""Appendix B List of Expert Consultants""; ""Appendix C Workshop Agendas""
""Appendix D Kurtzke�s Expanded Disability Status Scale (EDSS)""""Appendix E Drugs Used in the Treatment of MS""; ""Appendix F U.S. Social Security Administration�s Criteria for Qualifying as Disabled from MS""; ""Appendix G Treatments That Have Been Claimed to Be of Benefit in MS1""; ""Index"" |
| Record Nr. | UNINA-9910817571403321 |
| Washington, D.C., : National Academy Press, c2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
| Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors |
| Pubbl/distr/stampa | Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.549 |
| Altri autori (Persone) |
HoweCynthia J
JohnstonRichard B. <1935-> |
| Soggetto topico |
Poliomyelitis vaccine - United States
Poliomyelitis - Prevention |
| Soggetto genere / forma | Electronic books. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Options for Poliomyelitis Vaccination in the United States""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""History and Current Status""; ""U.S. EXPERIENCE ""; ""Recent Experience""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""EXPERIENCE IN OTHER PARTS OF THE AMERICAS""; ""Latin America""; ""Canada""; ""GLOBAL EXPERIENCE""; ""Options for Poliomyelitis Vaccination""; ""ORAL POLIOVIRUS VACCINE ONLY""; ""Vaccine Characteristics""; ""Current Use in the United States""; ""Immunity""; ""Safety""; ""INACTIVATED POLIOVIRUS VACCINE ONLY ""; ""Vaccine Characteristics""
""Current Use in the United States""""Immunity""; ""Safety""; ""IPV Experience in Western Europe""; ""General Comments""; ""SEQUENTIAL SCHEDULE FOR IPV AND OPV""; ""Public Health Experience""; ""Effect of a Sequential Series on the Occurrence of Vaccine-Associated Paralytic Poliomyelitis""; ""Immunogenicity and Shedding""; ""Summary""; ""PARENTAL CHOICE""; ""NO POLIO VACCINE ""; ""MODELING THE OPTIONS""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""Susceptible Population""; ""Remaining Questions""; ""Discussion""; ""Afterword""; ""References""; ""Abbreviations""; ""Workshop Agenda"" ""INSTITUTE OF MEDICINE VACCINE SAFETY FORUM""""History and Current Status of Poliomyelitis Vaccines""; ""Poliomyelitis Vaccine Characteristics""; ""Options for Poliomyelitis Vaccination""; ""CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Implementation Issues for Poliomyelitis Vaccination""; ""Considering the Options for Poliomyelitis Vaccination""; ""Discussion and Summary""; ""Workshop Speakers""; ""INSTITUTE OF MEDICINE AND CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Speakers and Session Chairs"" |
| Record Nr. | UNINA-9910451817203321 |
| Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
| Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors |
| Pubbl/distr/stampa | Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.549 |
| Altri autori (Persone) |
HoweCynthia J
JohnstonRichard B. <1935-> |
| Soggetto topico |
Poliomyelitis vaccine - United States
Poliomyelitis - Prevention |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Options for Poliomyelitis Vaccination in the United States""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""History and Current Status""; ""U.S. EXPERIENCE ""; ""Recent Experience""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""EXPERIENCE IN OTHER PARTS OF THE AMERICAS""; ""Latin America""; ""Canada""; ""GLOBAL EXPERIENCE""; ""Options for Poliomyelitis Vaccination""; ""ORAL POLIOVIRUS VACCINE ONLY""; ""Vaccine Characteristics""; ""Current Use in the United States""; ""Immunity""; ""Safety""; ""INACTIVATED POLIOVIRUS VACCINE ONLY ""; ""Vaccine Characteristics""
""Current Use in the United States""""Immunity""; ""Safety""; ""IPV Experience in Western Europe""; ""General Comments""; ""SEQUENTIAL SCHEDULE FOR IPV AND OPV""; ""Public Health Experience""; ""Effect of a Sequential Series on the Occurrence of Vaccine-Associated Paralytic Poliomyelitis""; ""Immunogenicity and Shedding""; ""Summary""; ""PARENTAL CHOICE""; ""NO POLIO VACCINE ""; ""MODELING THE OPTIONS""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""Susceptible Population""; ""Remaining Questions""; ""Discussion""; ""Afterword""; ""References""; ""Abbreviations""; ""Workshop Agenda"" ""INSTITUTE OF MEDICINE VACCINE SAFETY FORUM""""History and Current Status of Poliomyelitis Vaccines""; ""Poliomyelitis Vaccine Characteristics""; ""Options for Poliomyelitis Vaccination""; ""CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Implementation Issues for Poliomyelitis Vaccination""; ""Considering the Options for Poliomyelitis Vaccination""; ""Discussion and Summary""; ""Workshop Speakers""; ""INSTITUTE OF MEDICINE AND CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Speakers and Session Chairs"" |
| Record Nr. | UNINA-9910777419903321 |
| Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Options for poliomyelitis vaccination in the United States : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
| Options for poliomyelitis vaccination in the United States : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.549 |
| Altri autori (Persone) |
HoweCynthia J
JohnstonRichard B. <1935-> |
| Soggetto topico |
Poliomyelitis vaccine - United States
Poliomyelitis - Prevention |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Options for Poliomyelitis Vaccination in the United States""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""History and Current Status""; ""U.S. EXPERIENCE ""; ""Recent Experience""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""EXPERIENCE IN OTHER PARTS OF THE AMERICAS""; ""Latin America""; ""Canada""; ""GLOBAL EXPERIENCE""; ""Options for Poliomyelitis Vaccination""; ""ORAL POLIOVIRUS VACCINE ONLY""; ""Vaccine Characteristics""; ""Current Use in the United States""; ""Immunity""; ""Safety""; ""INACTIVATED POLIOVIRUS VACCINE ONLY ""; ""Vaccine Characteristics""
""Current Use in the United States""""Immunity""; ""Safety""; ""IPV Experience in Western Europe""; ""General Comments""; ""SEQUENTIAL SCHEDULE FOR IPV AND OPV""; ""Public Health Experience""; ""Effect of a Sequential Series on the Occurrence of Vaccine-Associated Paralytic Poliomyelitis""; ""Immunogenicity and Shedding""; ""Summary""; ""PARENTAL CHOICE""; ""NO POLIO VACCINE ""; ""MODELING THE OPTIONS""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""Susceptible Population""; ""Remaining Questions""; ""Discussion""; ""Afterword""; ""References""; ""Abbreviations""; ""Workshop Agenda"" ""INSTITUTE OF MEDICINE VACCINE SAFETY FORUM""""History and Current Status of Poliomyelitis Vaccines""; ""Poliomyelitis Vaccine Characteristics""; ""Options for Poliomyelitis Vaccination""; ""CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Implementation Issues for Poliomyelitis Vaccination""; ""Considering the Options for Poliomyelitis Vaccination""; ""Discussion and Summary""; ""Workshop Speakers""; ""INSTITUTE OF MEDICINE AND CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Speakers and Session Chairs"" |
| Record Nr. | UNINA-9910806258203321 |
| Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||